![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM50A |
Gene summary for TMEM50A |
![]() |
Gene information | Species | Human | Gene symbol | TMEM50A | Gene ID | 23585 |
Gene name | transmembrane protein 50A | |
Gene Alias | IFNRC | |
Cytomap | 1p36.11 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | O95807 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23585 | TMEM50A | GSM4909285 | Human | Breast | IDC | 2.50e-02 | -6.77e-02 | 0.21 |
23585 | TMEM50A | GSM4909286 | Human | Breast | IDC | 5.27e-10 | -2.48e-01 | 0.1081 |
23585 | TMEM50A | GSM4909288 | Human | Breast | IDC | 1.18e-02 | -2.95e-01 | 0.0988 |
23585 | TMEM50A | GSM4909293 | Human | Breast | IDC | 8.20e-07 | -1.70e-01 | 0.1581 |
23585 | TMEM50A | GSM4909294 | Human | Breast | IDC | 1.94e-11 | -3.87e-01 | 0.2022 |
23585 | TMEM50A | GSM4909296 | Human | Breast | IDC | 5.02e-16 | -2.97e-01 | 0.1524 |
23585 | TMEM50A | GSM4909297 | Human | Breast | IDC | 1.37e-18 | -2.92e-01 | 0.1517 |
23585 | TMEM50A | GSM4909298 | Human | Breast | IDC | 2.86e-07 | -2.29e-01 | 0.1551 |
23585 | TMEM50A | GSM4909301 | Human | Breast | IDC | 2.37e-06 | -2.00e-01 | 0.1577 |
23585 | TMEM50A | GSM4909302 | Human | Breast | IDC | 1.40e-08 | -3.41e-01 | 0.1545 |
23585 | TMEM50A | GSM4909304 | Human | Breast | IDC | 4.55e-02 | -1.48e-01 | 0.1636 |
23585 | TMEM50A | GSM4909309 | Human | Breast | IDC | 3.88e-04 | -1.64e-01 | 0.0483 |
23585 | TMEM50A | GSM4909311 | Human | Breast | IDC | 1.91e-44 | -5.58e-01 | 0.1534 |
23585 | TMEM50A | GSM4909312 | Human | Breast | IDC | 3.11e-22 | -3.86e-01 | 0.1552 |
23585 | TMEM50A | GSM4909313 | Human | Breast | IDC | 1.28e-06 | -1.82e-01 | 0.0391 |
23585 | TMEM50A | GSM4909316 | Human | Breast | IDC | 1.64e-04 | -4.04e-01 | 0.21 |
23585 | TMEM50A | GSM4909318 | Human | Breast | IDC | 4.79e-03 | -5.07e-01 | 0.2031 |
23585 | TMEM50A | GSM4909319 | Human | Breast | IDC | 1.26e-61 | -5.89e-01 | 0.1563 |
23585 | TMEM50A | GSM4909320 | Human | Breast | IDC | 1.50e-07 | -3.53e-01 | 0.1575 |
23585 | TMEM50A | GSM4909321 | Human | Breast | IDC | 8.78e-17 | -2.16e-01 | 0.1559 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000703422 | Oral cavity | EOLP | vacuolar transport | 36/2218 | 157/18723 | 6.66e-05 | 8.27e-04 | 36 |
GO:001619722 | Oral cavity | EOLP | endosomal transport | 45/2218 | 230/18723 | 4.63e-04 | 4.07e-03 | 45 |
GO:00161978 | Prostate | BPH | endosomal transport | 62/3107 | 230/18723 | 4.54e-05 | 4.77e-04 | 62 |
GO:00070349 | Prostate | BPH | vacuolar transport | 46/3107 | 157/18723 | 4.86e-05 | 5.07e-04 | 46 |
GO:00719854 | Prostate | BPH | multivesicular body sorting pathway | 14/3107 | 37/18723 | 1.58e-03 | 9.23e-03 | 14 |
GO:00453243 | Prostate | BPH | late endosome to vacuole transport | 10/3107 | 25/18723 | 4.57e-03 | 2.19e-02 | 10 |
GO:00325095 | Prostate | BPH | endosome transport via multivesicular body sorting pathway | 11/3107 | 31/18723 | 8.57e-03 | 3.68e-02 | 11 |
GO:000703414 | Prostate | Tumor | vacuolar transport | 48/3246 | 157/18723 | 3.18e-05 | 3.78e-04 | 48 |
GO:001619713 | Prostate | Tumor | endosomal transport | 62/3246 | 230/18723 | 1.65e-04 | 1.47e-03 | 62 |
GO:007198512 | Prostate | Tumor | multivesicular body sorting pathway | 15/3246 | 37/18723 | 7.46e-04 | 5.14e-03 | 15 |
GO:003250913 | Prostate | Tumor | endosome transport via multivesicular body sorting pathway | 12/3246 | 31/18723 | 3.92e-03 | 1.99e-02 | 12 |
GO:004532412 | Prostate | Tumor | late endosome to vacuole transport | 10/3246 | 25/18723 | 6.30e-03 | 2.89e-02 | 10 |
GO:001619716 | Skin | AK | endosomal transport | 41/1910 | 230/18723 | 2.76e-04 | 2.93e-03 | 41 |
GO:000703418 | Skin | AK | vacuolar transport | 27/1910 | 157/18723 | 4.70e-03 | 2.69e-02 | 27 |
GO:000703419 | Skin | cSCC | vacuolar transport | 74/4864 | 157/18723 | 8.60e-09 | 2.72e-07 | 74 |
GO:001619717 | Skin | cSCC | endosomal transport | 98/4864 | 230/18723 | 2.71e-08 | 7.41e-07 | 98 |
GO:00325098 | Skin | cSCC | endosome transport via multivesicular body sorting pathway | 22/4864 | 31/18723 | 2.00e-07 | 4.34e-06 | 22 |
GO:00453246 | Skin | cSCC | late endosome to vacuole transport | 18/4864 | 25/18723 | 1.91e-06 | 3.17e-05 | 18 |
GO:00719857 | Skin | cSCC | multivesicular body sorting pathway | 23/4864 | 37/18723 | 3.80e-06 | 5.70e-05 | 23 |
GO:00325114 | Skin | cSCC | late endosome to vacuole transport via multivesicular body sorting pathway | 12/4864 | 17/18723 | 1.48e-04 | 1.32e-03 | 12 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM50A | SNV | Missense_Mutation | c.32N>T | p.Ser11Leu | p.S11L | O95807 | protein_coding | tolerated(0.27) | benign(0.315) | TCGA-BH-A0AW-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | |
TMEM50A | deletion | Frame_Shift_Del | c.47delN | p.Glu18LysfsTer23 | p.E18Kfs*23 | O95807 | protein_coding | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
TMEM50A | SNV | Missense_Mutation | c.58N>T | p.Arg20Cys | p.R20C | O95807 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
TMEM50A | SNV | Missense_Mutation | c.262N>A | p.Leu88Met | p.L88M | O95807 | protein_coding | tolerated(0.14) | benign(0.284) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
TMEM50A | SNV | Missense_Mutation | c.124G>A | p.Ala42Thr | p.A42T | O95807 | protein_coding | tolerated(0.22) | possibly_damaging(0.531) | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD | |
TMEM50A | SNV | Missense_Mutation | novel | c.373G>T | p.Asp125Tyr | p.D125Y | O95807 | protein_coding | deleterious(0.05) | benign(0.167) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
TMEM50A | SNV | Missense_Mutation | rs774445401 | c.281N>A | p.Arg94His | p.R94H | O95807 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TMEM50A | SNV | Missense_Mutation | novel | c.467N>T | p.Trp156Leu | p.W156L | O95807 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
TMEM50A | SNV | Missense_Mutation | novel | c.62N>C | p.Asn21Thr | p.N21T | O95807 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM50A | SNV | Missense_Mutation | novel | c.265N>T | p.Gly89Cys | p.G89C | O95807 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A1C4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |